News for Genprex, Inc. (GNPX)

PR NewswireAUSTIN, Texas, Feb. 18, 2025 Signs an Amended & Restated License Agreement for Multiple Technologies for Gene Therapy for Type 1 and Type 2 Diab

Shares of Lattice Semiconductor Corporation LSCC rose sharply in pre-market trading after the company reported its fourth-quarter financial results after Monday...

PR NewswireAUSTIN, Texas, Jan. 6, 2025 AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-st

PR NewswireAUSTIN, Texas, Nov. 20, 2024 License includes Genprex's Reqorsa® Gene Therapy in Combination with ALK-Inhibitors for the Potential Treatment of

Texas-based CNS Pharmaceuticals, Inc., (CNSP), a clinical pharmaceutical company, is up over 143 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Texas-based CNS Pharmaceuticals, Inc., (CNSP), a clinical pharmaceutical company, is up over 143 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Shares of Stride, Inc. LRN rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and issued...

Regeneron Pharmaceuticals (REGN) experienced a significant stock decline, dropping by 5.01%. The stock is currently priced at $920.00 per share, with a trading

Ginkgo Bioworks Holdings, Inc. (DNA) saw its stock price increase by 5.21%, reaching $9.39 per share. The trading volume was 463,888 shares with a turnover rate

Advaxis, Inc. (ADXS), traded on the U.S. OTC market, recently experienced significant stock price volatility with a remarkable increase of 112.96%. The stock is

Aileron Therapeutics, Inc. (ALRN), a clinical-stage biopharmaceutical company, saw its stock price rise by 5.04%. The stock is currently priced at $3.75, with a

Therapeutics company Adagene (ADAG) experienced significant stock movement with a sharp decline of 7.04%. The stock is currently priced at $2.51 per share, with

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 150 points on Tuesday. Following the market opening Tuesday, the Dow traded d...

Texas-based Genprex, Inc. (GNPX), a clinical-stage gene therapy company is up over 103 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of iRhythm Technologies, Inc. IRTC rose sharply in today's pre-market trading after the company announced that it was granted FDA clearance for its 510(k...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80%

U.S. stocks traded mostly lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening Monday, the Dow traded do...

The increasing demand for clinical laboratory services is mainly driven by the rising prevalence of chronic and infectious diseases, lifestyle-related...

The growing demand for corporate wellness is largely driven by factors such as increased screen time, higher workloads, rapid urbanization, poor diet,...